MétaCan
Menu
Back to cohort
Record W2433847111 · doi:10.1093/neuonc/now073.49

HG-53HYPERMUTATION AND NEOANTIGEN FORMATION PREDICT RESPONSE TO IMMUNE CHECKPOINT INHIBITION IN CHILDHOOD BIALLELIC MISMATCH REPAIR DEFICIENT GLIOBLASTOMA

2016· article· en· W2433847111 on OpenAlexaff
Brittany Campbell, Éric Bouffet, Valérie Larouche, Gary Mason, Alyssa Reddy, Michael Osborn, Vanan Magimairan, Daniele Merico, Richard de Borja, Brian K. Chung, Melissa A. Galati, Melyssa Aronson, Carol Durno, Joerg Kruger, Vanja Cabric, Nataliya Zhukova, Vijay Ramaswamy, Roula Farah, Samina Afzal, Michal Yalon, Gideon Rechavi, Michael F. Walsh, Shlomi Constantini, Rina Dvir, Ronit Elhasid, Michael Sullivan, Jordan R. Hansford, Andrew Dodgshun, Nancy Klauber‐DeMore, Lindsay L. Peterson, Sunil J. Patel, Scott Lindhorst, Jeffrey Atkinson, Rachel Laframboise, Zane Cohen, Peter B. Dirks, Michael D. Taylor, David Malkin, Steffen Albrecht, Roy Dudley, Nada Jabado, Cynthia Hawkins, Adam Shlien, Uri Tabori

Bibliographic record

VenueNeuro-Oncology · 2016
Typearticle
Languageen
FieldMedicine
TopicRadiopharmaceutical Chemistry and Applications
Canadian institutionsMcGill University Health CentreMontreal Children's HospitalIzaak Walton Killam Health CentreUniversity of ManitobaMount Sinai HospitalCancerCare ManitobaResearch Institute in Oncology and HematologySickKids FoundationUniversité LavalHospital for Sick Children
Fundersnot available
KeywordsGlioblastomaDNA mismatch repairImmune systemMedicineCancer researchDNA repairImmunologyBiologyGeneticsGene

Abstract

fetched live from OpenAlex

Recurrent glioblastomas are universally lethal and common in the context of an aggressive cancer predisposition syndrome termed biallelic mismatch repair deficiency (bMMRD). bMMRD results in rapid onset of childhood cancers characterized by a high mutational burden. Evidence suggests that high mutation and neoantigen loads are associated with response to immune checkpoint inhibition (ICI). Exome sequencing and neoantigen prediction was performed on 37 bMMRD cancers and compared to childhood and adult neoplasms. Mutation and neoantigen load in bMMRD tumors were compared to adult melanomas, colorectal cancers and lung carcinomas that were responsive to ICIs. ICI were offered to bMMRD patients with recurrent tumors. bMMRD glioblastoma (n = 20) had significantly higher mutational load than sporadic pediatric and adult gliomas (p < 0.0001). bMMRD glioblastoma with secondary polymerase mutations had the highest mutation load (mean 17,740 + /-7703) in humans with mean neoantigen load 7-16 times higher than immunoresponsive adult tumors (p = 0.00001). Spatial and temporal sampling of individual bMMRD tumors revealed large variations in mutation and neoantigen landscape which is related to prior therapy. Based on these preclinical data, 6 bMMRD patients with recurrent glioblastoma are being treated with ICI with clinically significant and profound radiological responses. This report is the first to delineate the mutable nature of the neoantigen landscape in cancers where new mutations are constantly arising due to lack of replication repair. The encouraging responses of recurrent malignant brain tumors to immune checkpoint inhibition may have implications for other hypermutant cancers arising from primary (genetic predisposition) or secondary somatic mismatch repair deficiency

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.300
Teacher spread0.284 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-OncologySame topicRadiopharmaceutical Chemistry and ApplicationsFrench-language works237,207